These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12045671)

  • 1. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits.
    Tateishi N; Mori T; Kagamiishi Y; Satoh S; Katsube N; Morikawa E; Morimoto T; Matsui T; Asano T
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):723-34. PubMed ID: 12045671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion.
    Matsui T; Mori T; Tateishi N; Kagamiishi Y; Satoh S; Katsube N; Morikawa E; Morimoto T; Ikuta F; Asano T
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):711-22. PubMed ID: 12045670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of astrocytic activation by arundic acid (ONO-2506) mitigates detrimental effects of the apolipoprotein E4 isoform after permanent focal ischemia in apolipoprotein E knock-in mice.
    Mori T; Town T; Tan J; Tateishi N; Asano T
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):748-62. PubMed ID: 15689951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506.
    Mori T; Tateishi N; Kagamiishi Y; Shimoda T; Satoh S; Ono S; Katsube N; Asano T
    Neurochem Int; 2004; 45(2-3):381-7. PubMed ID: 15145552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice.
    Mori T; Town T; Kobayashi M; Tan J; Fujita SC; Asano T
    J Cereb Blood Flow Metab; 2004 Jun; 24(6):646-56. PubMed ID: 15181372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncosis, the possible cell death pathway in astrocytes after focal cerebral ischemia.
    Chu X; Fu X; Zou L; Qi C; Li Z; Rao Y; Ma K
    Brain Res; 2007 May; 1149():157-64. PubMed ID: 17433269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
    Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
    J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia.
    Yasuda Y; Tateishi N; Shimoda T; Satoh S; Ogitani E; Fujita S
    Brain Res; 2004 Sep; 1021(1):20-31. PubMed ID: 15328028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats.
    Lei B; Popp S; Capuano-Waters C; Cottrell JE; Kass IS
    Neuroscience; 2004; 125(3):691-701. PubMed ID: 15099683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B.
    Asano T; Mori T; Shimoda T; Shinagawa R; Satoh S; Yada N; Katsumata S; Matsuda S; Kagamiishi Y; Tateishi N
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):127-42. PubMed ID: 15857298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome.
    Codaccioni JL; Velly LJ; Moubarik C; Bruder NJ; Pisano PS; Guillet BA
    Anesthesiology; 2009 Jun; 110(6):1271-8. PubMed ID: 19417596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity.
    Hoshi A; Nakahara T; Kayama H; Yamamoto T
    J Neurosci Res; 2006 Jul; 84(1):130-41. PubMed ID: 16688719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
    Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
    Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice.
    Hata R; Maeda K; Hermann D; Mies G; Hossmann KA
    J Cereb Blood Flow Metab; 2000 Feb; 20(2):306-15. PubMed ID: 10698068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion.
    Fan Y; Shi L; Gu Y; Zhao Y; Xie J; Qiao J; Yang GY; Wang Y; Lu CZ
    J Cereb Blood Flow Metab; 2007 Apr; 27(4):719-28. PubMed ID: 16868556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats.
    Henninger N; Bouley J; Nelligan JM; Sicard KM; Fisher M
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1632-42. PubMed ID: 17311078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
    Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke.
    Gutiérrez-Fernández M; Rodríguez-Frutos B; Fuentes B; Vallejo-Cremades MT; Alvarez-Grech J; Expósito-Alcaide M; Díez-Tejedor E
    Neurochem Int; 2012 Feb; 60(3):310-7. PubMed ID: 22226841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
    Thiyagarajan M; Kaul CL; Sharma SS
    Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.